排序方式: 共有4条查询结果,搜索用时 15 毫秒
1
1.
Gustavo N. Marta Fernando F. de Arruda Fabiana A. Miranda Alice R.N.S. Silva Wellington F.P. Neves-Junior Anselmo Mancini Samir A. Hanna Carlos E.C.V. Abreu Joo Luis F. da Silva Jose Eduardo V. Nascimento Cecília Maria K. Haddad Fabio Y. Moraes Rafael Gadia 《Reports of Practical Oncology and Radiotherapy》2021,26(5):756
BackgroundThis study aims to assess the clinical outcomes of patients with spine metastases who underwent stereotactic ablative radiation therapy (SABR) as part of their treatment. SABR has arisen as a contemporary treatment option for spinal metastasis patients with good prognoses.Materials and methodsBetween November 2010 and September 2018, Spinal SABR was performed in patients with metastatic disease in different settings: radical (SABR only), postoperative (after decompression and/or fixation surgery), and reirradiation. Local control (LC), pain control, overall survival (OS) and toxicities were reported.ResultsEighty-five patients (corresponding to 96 treatments) with spine metastases were included. The median age was 59 years (range, 23–91). In most SA BR (82.3%, n = 79) was performed as the first local spine treatment, while in 12 settings (12.5%), fixation and/or decompression surgery was performed prior to SABR. Two-year overall survival rate was 74.1%, and median survival was 19 months. The LC rate at 2 years was 72.3%. With regard to pain control, among 67 patients presenting with pain before SA BR, 83.3% had a complete response, 12.1% had a partial response, and 4.6% had progression. Vertebral compression fractures occurred in 10 patients (11.7%), of which 5 cases occurred in the reirradiation setting. Radiculopathy and myelopathy were not observed. No grade III or IV toxicities were seen.ConclusionThis is the first study presenting a Brazilian experience with spinal SA BR, and the results confirm its feasibility and safety. SABR was shown to produce good local and pain control rates with low rates of adverse events. 相似文献
2.
Gupta Ankur Gadia Rohit Singh Ankit Singh Rajat Kumar Tiwari Akhilesh 《Plasmonics (Norwell, Mass.)》2022,17(1):143-151
Plasmonics - This paper dealt with the analysis of a surface plasmon resonance (SPR)-based D-shape photonic crystal fiber (PCF) biosensor for the detection of multimolecules present in a single... 相似文献
3.
4.
Rie Nadia Asso Anselmo Mancini Daniel Moore Freitas Palhares Wellington Furtado Pimenta Palhares Neves Junior Gustavo Nader Marta Joo Luis Fernandes da Silva Bibiana Ferreira Gouvea Ramos Rafael Gadia Samir Abdallah Hanna 《Reports of Practical Oncology and Radiotherapy》2022,27(4):593
BackgroundPatients with brain metastases (BM) live longer due to improved diagnosis and oncologic treatments. The association of volumetric modulated arc therapy (VMAT) and image-guided radiation therapy (IGRT) with brain radiosurgery (SRS) allows complex dose distributions and faster treatment delivery to multiple lesions.Materials and methodsThis study is a retrospective analysis of SRS for brain metastasis using VMAT. The primary endpoints were local disease-free survival (LDFS) and overall survival (OS). The secondary outcomes were intracranial disease-free survival (IDFS) and meningeal disease-free survival (MDFS).ResultsThe average number of treated lesions was 5.79 (range: 2–20) per treatment in a total of 113 patients. The mean prescribed dose was 18 Gy (range: 12–24 Gy). The median LDFS was 46 months. The LDFS in 6, 12, and 24 months was for 86%, 79%, and 63%, respectively. Moreover, brain progression occurred in 50 patients. The median overall survival was 47 months. The OS in 75%, 69%, and 61% patients was 6, 12, and 24 months, respectively. IDFS was 6 and 24 months in 35% and 14% patients, respectively. The mean MDFS was 62 months; it was 6 and 24 months for 87% and 83% of patients. Acute severe toxicity was relatively rare. During follow-up, the rates of radionecrosis and neurocognitive impairment were low (10%).ConclusionThe use of VMAT–SRS for multiple BM was feasible, effective, and associated with low treatment-related toxicity rates. Thus, treatment with VMAT is a safe technique to plan to achieve local control without toxicity. 相似文献
1